Photoswitchable Inhibitors to Optically Control Specific Kinase Activity

Tim Aguirre1,2, Ellen Teichmann1, Florian Q Römpp1,3,4

  • 1Department of Chemistry, Humboldt-Universität zu Berlin, Brook-Taylor-Street 2, 12489 Berlin, Germany.

Summary

Researchers developed photoswitchable azopyrazoles to control calcium-dependent protein kinase 1 (CDPK1) activity using light. These inhibitors show potential for treating infections like toxoplasmosis and cryptosporidiosis.